Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Sep;63(9):3659–3664. doi: 10.1128/iai.63.9.3659-3664.1995

Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix.

K Lähteenmäki 1, R Virkola 1, R Pouttu 1, P Kuusela 1, M Kukkonen 1, T K Korhonen 1
PMCID: PMC173507  PMID: 7642304

Abstract

The potential of bacterium-bound plasmin to degrade mammalian extracellular matrix and to enhance bacterial penetration through basement membrane was assessed with the adherent strain SH401-1 of Salmonella enterica serovar Typhimurium. Typhimurium SH401-1 was able to bind plasminogen and to enhance the tissue-type plasminogen activator-mediated activation of the single-chain plasminogen to the two-chain plasmin. The end product, the enzymatically active, bacterium-bound plasmin activity, was also formed in a normal human plasma milieu in the presence of exogenous tissue-type plasminogen activator, indicating that plasmin was protected from the plasminogen activator inhibitors and plasmin inhibitors of plasma. Plasmin bound on Typhimurium cells degraded 125I-labeled laminin as well as 3H-labeled extracellular matrix prepared from the human endothelial cell line EA.hy926. The degradations were not seen with Typhimurium cells without plasminogen and were inhibited by the low-molecular-weight plasmin inhibitor aprotinin. Plasmin bound on Typhimurium cells also potentiated penetration of bacterial cells through the basement membrane preparation Matrigel reconstituted on membrane filters. The results give in vitro evidence for degradation of the mammalian extracellular matrix by bacterium-bound plasmin and for a pathogenetic role for bacterial plasminogen receptors.

Full Text

The Full Text of this article is available as a PDF (272.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albini A., Iwamoto Y., Kleinman H. K., Martin G. R., Aaronson S. A., Kozlowski J. M., McEwan R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987 Jun 15;47(12):3239–3245. [PubMed] [Google Scholar]
  2. Berge A., Sjöbring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem. 1993 Dec 5;268(34):25417–25424. [PubMed] [Google Scholar]
  3. Brandtzaeg P., Joø G. B., Brusletto B., Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res. 1990 Jan 15;57(2):271–278. doi: 10.1016/0049-3848(90)90326-8. [DOI] [PubMed] [Google Scholar]
  4. Broder C. C., Lottenberg R., Boyle M. D. Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun. 1989 Sep;57(9):2597–2605. doi: 10.1128/iai.57.9.2597-2605.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broder C. C., Lottenberg R., von Mering G. O., Johnston K. H., Boyle M. D. Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem. 1991 Mar 15;266(8):4922–4928. [PubMed] [Google Scholar]
  6. Danø K., Andreasen P. A., Grøndahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139–266. doi: 10.1016/s0065-230x(08)60028-7. [DOI] [PubMed] [Google Scholar]
  7. Edgell C. J., McDonald C. C., Graham J. B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734–3737. doi: 10.1073/pnas.80.12.3734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hedman K., Johansson S., Vartio T., Kjellén L., Vaheri A., Hök M. Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell. 1982 Mar;28(3):663–671. doi: 10.1016/0092-8674(82)90221-5. [DOI] [PubMed] [Google Scholar]
  9. Hendrix M. J., Seftor E. A., Seftor R. E., Fidler I. J. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett. 1987 Dec;38(1-2):137–147. doi: 10.1016/0304-3835(87)90209-6. [DOI] [PubMed] [Google Scholar]
  10. Kienle Z., Emödy L., Svanborg C., O'Toole P. W. Adhesive properties conferred by the plasminogen activator of Yersinia pestis. J Gen Microbiol. 1992 Aug;138(Pt 8):1679–1687. doi: 10.1099/00221287-138-8-1679. [DOI] [PubMed] [Google Scholar]
  11. Kleinman H. K., McGarvey M. L., Hassell J. R., Star V. L., Cannon F. B., Laurie G. W., Martin G. R. Basement membrane complexes with biological activity. Biochemistry. 1986 Jan 28;25(2):312–318. doi: 10.1021/bi00350a005. [DOI] [PubMed] [Google Scholar]
  12. Korhonen T. K., Virkola R., Lähteenmäki K., Björkman Y., Kukkonen M., Raunio T., Tarkkanen A. M., Westerlund B. Penetration of fimbriate enteric bacteria through basement membranes: a hypothesis. FEMS Microbiol Lett. 1992 Dec 15;100(1-3):307–312. doi: 10.1111/j.1574-6968.1992.tb14057.x. [DOI] [PubMed] [Google Scholar]
  13. Kukkonen M., Raunio T., Virkola R., Lähteenmäki K., Mäkelä P. H., Klemm P., Clegg S., Korhonen T. K. Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol Microbiol. 1993 Jan;7(2):229–237. doi: 10.1111/j.1365-2958.1993.tb01114.x. [DOI] [PubMed] [Google Scholar]
  14. Kuusela P., Saksela O. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand. Eur J Biochem. 1990 Nov 13;193(3):759–765. doi: 10.1111/j.1432-1033.1990.tb19397.x. [DOI] [PubMed] [Google Scholar]
  15. Kuusela P., Ullberg M., Saksela O., Kronvall G. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci. Infect Immun. 1992 Jan;60(1):196–201. doi: 10.1128/iai.60.1.196-201.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Leytus S. P., Bowles L. K., Konisky J., Mangel W. F. Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1485–1489. doi: 10.1073/pnas.78.3.1485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Liotta L. A., Rao C. N., Wewer U. M. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem. 1986;55:1037–1057. doi: 10.1146/annurev.bi.55.070186.005133. [DOI] [PubMed] [Google Scholar]
  19. Lottenberg R., Broder C. C., Boyle M. D., Kain S. J., Schroeder B. L., Curtiss R., 3rd Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol. 1992 Aug;174(16):5204–5210. doi: 10.1128/jb.174.16.5204-5210.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lottenberg R., Minning-Wenz D., Boyle M. D. Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol. 1994 Jan;2(1):20–24. doi: 10.1016/0966-842x(94)90340-9. [DOI] [PubMed] [Google Scholar]
  21. Lundrigan M. D., Webb R. M. Prevalence of ompT among Escherichia coli isolates of human origin. FEMS Microbiol Lett. 1992 Oct 1;76(1-2):51–56. doi: 10.1016/0378-1097(92)90362-r. [DOI] [PubMed] [Google Scholar]
  22. Lähteenmäki K., Westerlund B., Kuusela P., Korhonen T. K. Immobilization of plasminogen on Escherichia coli flagella. FEMS Microbiol Lett. 1993 Feb 1;106(3):309–314. doi: 10.1111/j.1574-6968.1993.tb05981.x. [DOI] [PubMed] [Google Scholar]
  23. Mangel W. F., Lin B. H., Ramakrishnan V. Characterization of an extremely large, ligand-induced conformational change in plasminogen. Science. 1990 Apr 6;248(4951):69–73. doi: 10.1126/science.2108500. [DOI] [PubMed] [Google Scholar]
  24. Markwell M. A., Fox C. F. Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry. 1978 Oct 31;17(22):4807–4817. doi: 10.1021/bi00615a031. [DOI] [PubMed] [Google Scholar]
  25. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993 Jan;73(1):161–195. doi: 10.1152/physrev.1993.73.1.161. [DOI] [PubMed] [Google Scholar]
  26. Moscatelli D. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells. J Cell Biochem. 1986;30(1):19–29. doi: 10.1002/jcb.240300104. [DOI] [PubMed] [Google Scholar]
  27. Pancholi V., Fischetti V. A. A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med. 1992 Aug 1;176(2):415–426. doi: 10.1084/jem.176.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Parkkinen J., Hacker J., Korhonen T. K. Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis. Thromb Haemost. 1991 May 6;65(5):483–486. [PubMed] [Google Scholar]
  29. Parkkinen J., Korhonen T. K. Binding of plasminogen to Escherichia coli adhesion proteins. FEBS Lett. 1989 Jul 3;250(2):437–440. doi: 10.1016/0014-5793(89)80772-0. [DOI] [PubMed] [Google Scholar]
  30. Reich R., Thompson E. W., Iwamoto Y., Martin G. R., Deason J. R., Fuller G. C., Miskin R. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res. 1988 Jun 15;48(12):3307–3312. [PubMed] [Google Scholar]
  31. Repesh L. A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis. 1989;9(3):192–208. [PubMed] [Google Scholar]
  32. Rupprecht K. R., Gordon G., Lundrigan M., Gayda R. C., Markovitz A., Earhart C. omp T: Escherichia coli K-12 structural gene for protein a (3b). J Bacteriol. 1983 Feb;153(2):1104–1106. doi: 10.1128/jb.153.2.1104-1106.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Saksela O., Rifkin D. B. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol. 1988;4:93–126. doi: 10.1146/annurev.cb.04.110188.000521. [DOI] [PubMed] [Google Scholar]
  34. Sjöbring U., Pohl G., Olsén A. Plasminogen, absorbed by Escherichia coli expressing curli or by Salmonella enteritidis expressing thin aggregative fimbriae, can be activated by simultaneously captured tissue-type plasminogen activator (t-PA). Mol Microbiol. 1994 Nov;14(3):443–452. doi: 10.1111/j.1365-2958.1994.tb02179.x. [DOI] [PubMed] [Google Scholar]
  35. Sodeinde O. A., Goguen J. D. Nucleotide sequence of the plasminogen activator gene of Yersinia pestis: relationship to ompT of Escherichia coli and gene E of Salmonella typhimurium. Infect Immun. 1989 May;57(5):1517–1523. doi: 10.1128/iai.57.5.1517-1523.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sodeinde O. A., Subrahmanyam Y. V., Stark K., Quan T., Bao Y., Goguen J. D. A surface protease and the invasive character of plague. Science. 1992 Nov 6;258(5084):1004–1007. doi: 10.1126/science.1439793. [DOI] [PubMed] [Google Scholar]
  37. Suffredini A. F., Harpel P. C., Parrillo J. E. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med. 1989 May 4;320(18):1165–1172. doi: 10.1056/NEJM198905043201802. [DOI] [PubMed] [Google Scholar]
  38. Ullberg M., Kronvall G., Karlsson I., Wiman B. Receptors for human plasminogen on gram-negative bacteria. Infect Immun. 1990 Jan;58(1):21–25. doi: 10.1128/iai.58.1.21-25.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ullberg M., Kronvall G., Wiman B. New receptor for human plasminogen on gram positive cocci. APMIS. 1989 Nov;97(11):996–1002. doi: 10.1111/j.1699-0463.1989.tb00508.x. [DOI] [PubMed] [Google Scholar]
  40. Ullberg M., Kuusela P., Kristiansen B. E., Kronvall G. Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin. J Infect Dis. 1992 Dec;166(6):1329–1334. doi: 10.1093/infdis/166.6.1329. [DOI] [PubMed] [Google Scholar]
  41. Virkola R., Parkkinen J., Hacker J., Korhonen T. K. Sialyloligosaccharide chains of laminin as an extracellular matrix target for S fimbriae of Escherichia coli. Infect Immun. 1993 Oct;61(10):4480–4484. doi: 10.1128/iai.61.10.4480-4484.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Westerlund B., Korhonen T. K. Bacterial proteins binding to the mammalian extracellular matrix. Mol Microbiol. 1993 Aug;9(4):687–694. doi: 10.1111/j.1365-2958.1993.tb01729.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES